Weekly diabetes injection tested for safety in chilean patients
NCT ID NCT05533632
Summary
This study tested the safety and effects of weekly semaglutide injections in 104 Chilean adults with type 2 diabetes over 24 weeks. Participants received injections and were monitored for side effects, blood sugar control, and weight changes. The goal was to understand how well this already-approved medication works in a specific population and its safety profile.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Padre Hurtado
Santiago, Región Metropolitana, 8880465, Chile
-
Hospital San Juan de Dios_Santiago, Región Metropolitana
Santiago, Región Metropolitana, 8350429, Chile
-
Servicios Médicos Godoy Limitada
Santiago, Región Metropolitana, 7500710, Chile
Conditions
Explore the condition pages connected to this study.